Cleerly LABS vs DeepTek CXR Analyzer
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if your primary need is a comprehensive, AI-powered analysis of coronary CT angiography (CCTA) to precisely quantify atherosclerosis and stenosis. This tool is ideal for cardiologists and radiologists focused on personalized heart disease management, including detailed risk assessment and tracking disease progression over time.
View Cleerly LABS →Choose DeepTek CXR Analyzer if…
Choose DeepTek CXR Analyzer if you require an efficient, FDA-cleared AI-powered CADe solution to assist with high-volume chest X-ray interpretations. This tool is best suited for radiology departments aiming to significantly improve workflow efficiency and diagnostic accuracy by automatically detecting and highlighting suspicious regions across various lung, pleural, and cardiac pathologies.
View DeepTek CXR Analyzer →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | DeepTek CXR Analyzer |
|---|---|---|
| Pricing | Varies | Global access pricing available for eligible public sector and not-for-profit healthcare providers in 138 low- and middle-income countries, offering unlimited ai analyses per connected x-ray unit, installation, user training, product updates, maintenance, and technical support via an annual subscription. |
| Deployment | Cloud, On-premise | On-premise and Cloud offerings. The solution supports online, offline, and hybrid deployment. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
DeepTek CXR AnalyzerDeepTek CXR Analyzer's focus on seamless, backend integration, intelligent triaging, and direct DICOM output for easy interpretation suggests a highly streamlined and less disruptive workflow for radiologists. This approach aims to reduce workload and boost productivity by fitting directly into existing processes, making it highly usable in high-volume environments.
Clinical Value
Cleerly LABSWhile both are FDA-cleared and offer significant clinical value, Cleerly LABS provides a more transformative clinical impact by moving beyond simple detection to comprehensive plaque characterization, personalized risk assessment, and tracking disease progression for a critical condition like CAD. This depth of analysis and its proven ability to reduce unnecessary invasive procedures offer a higher level of personalized and preventative care.
Pricing & Value
Cleerly LABSCleerly LABS, despite its initial high retail price, now has established and expanding insurance coverage from major payors, including UnitedHealthcare, Cigna, Aetna, and Medicare, significantly improving its accessibility and reducing patient out-of-pocket expenses. This widespread coverage provides a more concrete and quantifiable value proposition for patients and providers compared to DeepTek's less transparent 'pay-per-use' model, even with its claimed productivity gains.
Enterprise Readiness
DeepTek CXR AnalyzerWhile both are FDA-cleared, HIPAA compliant, and offer BAA, DeepTek CXR Analyzer provides greater deployment flexibility with both cloud and on-premise options, catering to a wider range of enterprise IT infrastructures and security preferences. Furthermore, its extensive list of international regulatory approvals and certifications (ISO 13485, ISO 27001, GDPR, SOC 2) demonstrates a more robust and globally-minded approach to enterprise readiness.
Innovation
Cleerly LABSCleerly LABS demonstrates a higher degree of innovation by fundamentally shifting the paradigm of cardiovascular disease management from stenosis-focused detection to comprehensive plaque characterization, personalized risk assessment, and disease progression tracking. This proactive and preventative approach, supported by advanced 3D visualization and AI, represents a more transformative application of AI in clinical practice.
Support & Docs
Cleerly LABSCleerly LABS provides clear and explicit information regarding its customer support availability, including specific hours of operation (Monday-Friday, 10 am ET to 6 pm ET) and a dedicated online form for existing users to request technical assistance. While DeepTek hints at a robust support infrastructure through its '140+ Experts delivering 24x7 services' for its reporting service, it lacks specific details about support for its CXR Analyzer software, making Cleerly's offering more transparent.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | DeepTek CXR Analyzer |
|---|---|---|
| Tool Name | Cleerly LABS | DeepTek CXR Analyzer |
| Company | Cleerly | DeepTek Medical Imaging Pvt |
| Primary Imaging Modality | Coronary CT Angiography (CCTA) | Chest X-ray |
| Key AI Capabilities | AI-powered CCTA image analysis, comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, ischemia detection (with Cleerly ISCHEMIA module), 3D visualization of coronary arteries, personalized heart disease risk assessment, tracking disease progression over time | AI-Powered Computer-Assisted Detection (CADe) for Chest X-rays, detection of 28 findings covering lung, pleural, cardiac pathologies, and hardware, automatic identification, categorization, and highlighting of suspicious regions of interest (ROIs), intelligent segregation of scans into 'AI Finding-Negative' and 'AI Finding-Positive' |
| Specialties | Cardiology, Radiology | Cardiology, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and DeepTek CXR Analyzer.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or DeepTek CXR Analyzer
Backers
Who funded each tool's parent company.